Table 1.
Groups | n | Gender, male | Age at scan (y) | Disease Duration (y) | Clinical Diagnosis |
---|---|---|---|---|---|
controls | 97 | 43 (44%) | 62.1 (11.1) | – | — |
MAPT | 29 | 17 (59%) | 55.3 (7.9) | 5.5 (3.3) | 28 bvFTD, 1 PNFA |
GRN | 18 | 9 (50%) | 62.2 (6.4) | 3.0 (2.6) | 11 bvFTD, 5 PNFA, 2 PPA-NOS |
C9orf72 | 28 | 20 (71%) | 61.5 (6.7) | 6.0 (3.6) | 24 bvFTD, 2 PNFA, 2 FTD-MND |